ketoconazole has been researched along with calcipotriene in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Birkenhäger, JC; Bos, MP; Pols, HA; Schilte, JP; van Leeuwen, JP | 1 |
Phillips, SB; Potts, CE; Shelanski, MV | 1 |
Deng, CH; Huang, X; Krochmal, L; Lenn, J; Tanojo, H | 1 |
1 review(s) available for ketoconazole and calcipotriene
Article | Year |
---|---|
A novel foam vehicle for delivery of topical corticosteroids.
Topics: Administration, Cutaneous; Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betamethasone; Body Water; Calcitriol; Clindamycin; Clobetasol; Dermatologic Agents; Dosage Forms; Hot Temperature; Humans; Ketoconazole; Ointments; Pharmaceutical Vehicles; Skin; Skin Absorption | 2005 |
1 trial(s) available for ketoconazole and calcipotriene
Article | Year |
---|---|
Evaluation of cutaneous reactivity to recently marketed dermatologic products.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antifungal Agents; Calcitriol; Clobetasol; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Doxepin; Drug Prescriptions; Female; Humans; Hypersensitivity; Imidazoles; Irritants; Ketoconazole; Male; Metronidazole; Middle Aged; Mupirocin; Naphthalenes; Patch Tests; Pharmaceutical Vehicles; Placebos; Risk Factors; Skin; Terbinafine | 1996 |
2 other study(ies) available for ketoconazole and calcipotriene
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption.
Topics: Animals; Binding Sites; Bone Resorption; Calcitriol; Calcium; Cell Division; Cell Line; Cytochrome P-450 Enzyme System; Enzyme Induction; Ketoconazole; Mice; Osteoblasts; Oxidation-Reduction; Receptors, Calcitriol; Receptors, Steroid; Steroid Hydroxylases; Up-Regulation; Vitamin D3 24-Hydroxylase | 1991 |